Artelo Biosciences Inc.

NASDAQ: ARTLW · Real-Time Price · USD
0.01
0.00 (78.57%)
At close: Jun 17, 2024, 10:00 PM

Artelo Biosciences Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Aug 31, 2021
Net Income
-10.08M -7.44M
Depreciation & Amortization
n/a n/a
Stock-Based Compensation
2.46M 1.53M
Other Working Capital
-195K -239K
Other Non-Cash Items
-211K 7K
Deferred Income Tax
n/a n/a
Change in Working Capital
-172K -242K
Operating Cash Flow
-8.01M -6.14M
Capital Expenditures
n/a n/a
Cash Acquisitions
n/a n/a
Purchase of Investments
-13.22M -3.44M
Sales Maturities Of Investments
16.18M n/a
Other Investing Acitivies
n/a n/a
Investing Cash Flow
2.96M -3.44M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
n/a 6.01M
Financial Cash Flow
n/a 14.11M
Net Cash Flow
-5.27M 4.49M
Free Cash Flow
-8.01M -6.14M